These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28332361)

  • 1. Occult HBV among Anti-HBc Alone: Mutation Analysis of an HBV Surface Gene and Pre-S Gene.
    Kim MH; Kang SY; Lee WI
    Yonsei Med J; 2017 May; 58(3):557-563. PubMed ID: 28332361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
    Launay O; Masurel J; Servant-Delmas A; Basse-Guérineau AL; Méritet JF; Laperche S; Sogni P; Rosenberg AR
    J Viral Hepat; 2011 Oct; 18(10):721-9. PubMed ID: 21914087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
    Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO
    AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of "anti-HBc alone" and HBV DNA detection among anti-HBc alone in Korea.
    Kang SY; Kim MH; Lee WI
    J Med Virol; 2010 Sep; 82(9):1508-14. PubMed ID: 20648604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti-hepatitis B core antigen alone subjects.
    Azarkar Z; Ziaee M; Ebrahimzadeh A; Sharifzadeh G; Javanmard D
    J Med Virol; 2019 Apr; 91(4):615-622. PubMed ID: 30345529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.
    Vargas JI; Jensen D; Sarmiento V; Peirano F; Acuña P; Fuster F; Soto S; Ahumada R; Huilcaman M; Bruna M; Jensen W; Fuster F
    J Med Virol; 2016 Apr; 88(4):639-46. PubMed ID: 26381185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
    Coffin CS; Mulrooney-Cousins PM; Osiowy C; van der Meer F; Nishikawa S; Michalak TI; van Marle G; Gill MJ
    J Clin Virol; 2014 Aug; 60(4):347-53. PubMed ID: 24881491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of occult hepatitis B virus infection in anti-hbc positive patients from a liver clinic.
    Martinez MC; Kok CC; Baleriola C; Robertson P; Rawlinson WD
    PLoS One; 2015; 10(3):e0117275. PubMed ID: 25763579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
    Datta S; Banerjee A; Chandra PK; Chowdhury A; Chakravarty R
    J Med Virol; 2006 Jan; 78(1):53-9. PubMed ID: 16299727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil.
    Silva CM; Costi C; Costa C; Michelon C; Oravec R; Ramos AB; Niel C; Rossetti ML
    J Infect; 2005 Jul; 51(1):24-9. PubMed ID: 15979486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran.
    Ramezani A; Banifazl M; Eslamifar A; Aghakhani A
    J Infect Dev Ctries; 2010 Oct; 4(10):658-61. PubMed ID: 21045360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B virus infection in hemodialysis patients in Recife, State of Pernambuco, Brazil.
    Albuquerque AC; Coelho MR; Lemos MF; Moreira RC
    Rev Soc Bras Med Trop; 2012 Oct; 45(5):558-62. PubMed ID: 23152336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.
    Wang Q; Sachse P; Semmo M; Lokhande M; Montani M; Dufour JF; Zoulim F; Klenerman P; Semmo N
    J Viral Hepat; 2015 Dec; 22(12):1068-78. PubMed ID: 26075501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B.
    Huang X; Qin Y; Li W; Shi Q; Xue Y; Li J; Liu C; Hollinger FB; Shen Q
    J Med Virol; 2013 Jun; 85(6):979-86. PubMed ID: 23588723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
    Kang SY; Kim MH; Lee WI
    Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course and core variability in HBV infected patients without detectable anti-HBc antibodies.
    Anastasiou OE; Widera M; Verheyen J; Korth J; Gerken G; Helfritz FA; Canbay A; Wedemeyer H; Ciesek S
    J Clin Virol; 2017 Aug; 93():46-52. PubMed ID: 28622640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.